Human stem cell culture medium-containing composition

JP2026122744APending Publication Date: 2026-07-29YURARA CO LTD

View PDF 1 Cites 0 Cited by

Patent Information

Authority / Receiving Office: JP · JP
Patent Type: Applications
Current Assignee / Owner: YURARA CO LTD
Filing Date: 2025-01-16
Publication Date: 2026-07-29

AI Technical Summary

Benefits of technology

【0006】 この発明により、新規な効果が得られるヒト幹細胞培養液含有組成物を提供することができる。

✦ Generated by Eureka AI based on patent content.

Smart Images

Figure 2026122744000001_ABST

Patent Text Reader

Abstract

The objective is to provide a human stem cell culture medium-containing composition that can produce novel effects. [Solution] A human stem cell culture medium-containing composition containing human stem cell culture supernatant, which is the supernatant obtained when stem cells collected from humans (human stem cells) are cultured in a culture medium, and nicotinamide mononucleotide.

Need to check novelty before this filing date? Find Prior Art

Claims

1. Human stem cell culture supernatant and Contains nicotinamide mononucleotide and Composition containing human stem cell culture medium.

2. The human stem cell culture supernatant is characterized by being prepared using human stem cells from five generations or earlier in subculture. A human stem cell culture medium-containing composition according to claim 1.

3. The aforementioned human stem cells are characterized by being cells derived from the umbilical cord. The human stem cell culture medium-containing composition according to claim 2.

4. This composition is characterized by being a composition for lowering uric acid levels. The human stem cell culture medium-containing composition according to claim 3.

5. A composition characterized by being used to lower blood sugar levels. The human stem cell culture medium-containing composition according to claim 4.

6. To 10 ml of the aforementioned human stem cell culture supernatant, This product is characterized by containing 450 to 550 mg of the aforementioned nicotinamide mononucleotide. A human stem cell culture medium-containing composition according to any one of claims 1 to 5.

7. A human stem cell culture medium-containing composition according to any one of claims 1 to 5 is mixed into an intravenous fluid. Intravenous fluid.